Profile data is unavailable for this security.
About the company
SomnoMed Limited is an Australia-based company, which is engaged in producing and selling devices for the oral treatment of sleep-related disorders. The Company provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is focused on the commercialization of the SomnoDent and other oral devices for sleep-related disorders. The Company’s segments include North America, Europe, Asia Pacific, CORE, and RSS. Its SomnoDent product line includes SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite and Herbst Advance. Its SomMorning Repositioner is designed to help return their mandible back to its pre-treatment centric position. Its SomnoBrux Michigan splint is a custom fit, acrylic splint (dental guard) for upper teeth designed to protect the teeth from grinding and scraping during Bruxism. It also offers SomTabs, which are cleaning tablets that are developed to clean oral appliances.
- Revenue in AUD (TTM)88.78m
- Net income in AUD-10.51m
- Incorporated1987
- Employees300.00
- LocationSomnomed LtdLevel 3, 20 Clarke St, Crows NestSYDNEY 2065AustraliaAUS
- Phone+61 29467-0400
- Fax+61 29467-0467
- Websitehttps://somnomed.com/en/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wellnex Life Ltd | 20.31m | -19.39m | 32.24m | -- | -- | 4.16 | -- | 1.59 | -0.0347 | -0.0347 | 0.0359 | 0.006 | 0.712 | 2.97 | 4.64 | -- | -67.96 | -79.54 | -133.68 | -99.28 | 12.77 | 10.10 | -95.45 | -235.50 | 0.2654 | -5.24 | 0.5516 | -- | 49.81 | 77.66 | -85.88 | -- | -- | -- |
| Universal Biosensors, Inc. | 6.81m | -6.39m | 41.73m | 97.00 | -- | 1.84 | -- | 6.13 | -0.0304 | -0.0304 | 0.0315 | 0.0762 | 0.1941 | 0.6025 | 3.61 | -- | -18.23 | -21.79 | -24.51 | -27.14 | 62.97 | 46.16 | -93.90 | -209.31 | 3.02 | -- | 0.0342 | -- | 46.58 | -37.48 | 74.90 | -- | 26.83 | -- |
| Curvebeam AI Ltd | 8.78m | -57.55m | 42.62m | 50.00 | -- | 1.32 | -- | 4.86 | -0.18 | -0.18 | 0.0275 | 0.1477 | 0.1347 | 0.5618 | 3.47 | -- | -88.33 | -- | -115.31 | -- | 48.78 | -- | -655.67 | -- | 1.97 | -3.10 | 0.2364 | -- | 381.77 | -- | -509.11 | -- | -- | -- |
| Nova Eye Medical Ltd | 18.70m | -14.31m | 51.49m | 130.00 | -- | 2.59 | -- | 2.75 | -0.0797 | -0.0797 | 0.102 | 0.087 | 0.6805 | 0.4822 | 8.34 | -- | -52.10 | -12.19 | -64.18 | -14.93 | 90.20 | 82.04 | -76.56 | -60.21 | 0.8106 | -- | 0.0666 | -- | 27.71 | -26.42 | -104.02 | -- | -28.45 | -- |
| Compumedics Limited | 49.62m | 1.23m | 53.15m | 135.00 | 42.13 | 2.95 | 20.75 | 1.07 | 0.0071 | 0.0071 | 0.3107 | 0.1018 | 1.24 | 2.14 | 4.43 | 367,540.80 | 3.07 | -2.91 | 6.53 | -4.63 | 53.54 | 53.44 | 2.48 | -2.90 | 0.7483 | 2.01 | 0.3385 | -- | 12.32 | 2.76 | -551.14 | -- | 16.84 | -- |
| Micro-X Ltd | 15.17m | -14.51m | 54.04m | -- | -- | 4.84 | -- | 3.56 | -0.0281 | -0.0281 | 0.0294 | 0.0192 | 0.5425 | 0.8518 | 9.08 | -- | -51.87 | -43.99 | -67.43 | -59.14 | 63.58 | 65.04 | -95.61 | -130.78 | 1.28 | -56.11 | 0.3033 | -- | 14.42 | 22.25 | 37.07 | -- | 23.88 | -- |
| Somnomed Ltd | 88.78m | -10.51m | 57.27m | 300.00 | -- | 1.24 | -- | 0.6451 | -0.0917 | -0.0926 | 0.7822 | 0.2131 | 1.38 | 7.76 | 7.52 | -- | -16.35 | -5.23 | -22.50 | -7.84 | 61.76 | 60.17 | -11.84 | -4.13 | 1.45 | -2.03 | 0.3827 | -- | 15.21 | 5.56 | -77.73 | -- | 24.17 | -- |
| Orthocell Ltd | 6.06m | -7.42m | 77.45m | -- | -- | 33.85 | -- | 12.79 | -0.0369 | -0.0369 | 0.0301 | 0.0109 | 0.2182 | 1.50 | 27.68 | -- | -26.73 | -32.67 | -31.96 | -38.53 | 77.11 | 63.04 | -122.55 | -374.46 | 4.36 | -- | 0.2586 | -- | 215.24 | 51.53 | 31.39 | -- | 11.07 | -- |
| Holder | Shares | % Held |
|---|---|---|
| TDMAM Pty Ltd.as of 25 Sep 2023 | 42.09m | 19.48% |
| Australian Ethical Investments Ltd. (Investment Management)as of 08 May 2024 | 34.24m | 15.85% |
| FIL Investment Management (Hong Kong) Ltd.as of 30 Apr 2024 | 14.14m | 6.54% |
| Fidelity Management & Research Co. LLCas of 22 Dec 2023 | 5.72m | 2.65% |
| FIAM LLCas of 22 Dec 2023 | 497.68k | 0.23% |
| QS Investors LLCas of 31 Mar 2024 | 433.97k | 0.20% |
